August 07, 2025 In The NewsHistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier InvestorsBusinessWire
August 07, 2025 In The NewsLiver Tumor Therapy Company HistoSonics Valued at $2.25 Billion in SaleWall Street Journal
August 15, 2024 Press ReleasesFox Rothschild Represents HistoSonics in $102 Million Series D Financing
March 25, 2024 Press ReleasesPatrice Kloss Selected to Minneapolis/St. Paul Business Journal’s Women in Business List
August 31, 2022 In The NewsXtant Medical Announces Closing of First Tranche of $9.75 Million Private InvestmentGlobe Newswire
January 07, 2020 In The NewsTechnology Will Propel Compliance Trends in 2020Medical Practice Compliance Alert
April 29, 2019 In The NewsMental Health Apps Sharing Health Data Without Disclosure or ConsentLexBlog
October 22, 2018 In The NewsPurdue Pharma L.P. Enters into Exclusive Option Agreement to Acquire SpineThera, Inc. and Its Non-Opioid Product
October 05, 2018 In The NewsQ&A: Tom Letscher and Patrice Kloss, Partners, Fox Rothschild Medical Technology PracticeMinnesota Lawyer